Posted on 04.15.2021 by Chandana Sirimalwatte in World with 0 Comments
Denmark has discontinued the Oxford-AstraZeneca vaccine with reports of blood clots in some of those who received the vaccine.
Last week, in an announcement European Medicines Agency acknowledged that the vaccine was linked to clots and the risk of Covid-19 death was even higher. Several European countries have previously suspended the use of the AstraZeneca vaccine.
Meanwhile, the United States, Canada and the European Union have suspended the Johnson & Johnson vaccine due to problems with blood clotting. South Africa, which used the Johnson & Johnson vaccine, has also discontinued its use due to increased efficacy against the South African variety.
However, according to statistics, the side effects of blood clotting are minimal among people who have been given both AstraZeneca and Johnson & Johnson vaccines.
In this way, the EU’s withdrawal of the vaccine poses a challenge to the World Health Organization (WHO)’s failure to make a decision on the issue.
A spokesman for AstraZeneca said in response to the Danish decision that it respects the decision of the Danish health authorities. The statement acknowledged that health care authorities in each country must be the authority to initiate, conduct and discontinue vaccination programs, and provide all data related to their product to assist in making such decisions.